Ultra-Fast Vitrification: Minimizing the Toxicity of Cryoprotective Agents and Osmotic Stress in Mouse Oocyte Cryopreservation.
Jung-Ran ChoEun-Hee YuHyun Joo LeeIn-Hye KimJi-Hye JeongDan-Bi LeeSeong-Keun ChoJong-Kil JooPublished in: International journal of molecular sciences (2024)
Globally, women have been adopting oocyte cryopreservation (OC) for fertility preservation for various reasons, such as inevitable gonadotoxic treatment for specific pathologic states and social preferences. While conventional vitrification (C-VIT) has improved the success rate of OC, challenges of possible toxicities of high-concentration cryoprotective agents and osmotic stress persist. To overcome these challenges, we evaluated the ultra-fast vitrification (UF-VIT) method, which reduces the equilibration solution stage exposure time compared to C-VIT by observing mouse oocyte intracellular organelles and embryonic development. Consequently, compared to fresh mouse oocytes, UF-VIT presented significant differences only in endoplasmic reticulum (ER) intensity and mitochondrial (MT) distribution. Meanwhile, C-VIT showed substantial differences in the survival rate, key ER and MT parameters, and embryonic development rate. UF-VIT exhibited considerably fewer negative effects on key MT parameters and resulted in a notably higher blastocyst formation rate than C-VIT. Meiotic spindle (spindle and chromosomes) morphology showed no significant changes between the groups during vitrification/warming (VW), suggesting that VW did not negatively affect the meiotic spindle of the oocytes. In conclusion, UF-VIT seems more effective in OC owing to efficient cytoplasmic water molecule extraction, osmotic stress reduction, and minimization of cell contraction and expansion amplitude, thus compensating for the drawbacks of C-VIT.
Keyphrases
- endoplasmic reticulum
- healthcare
- oxidative stress
- high resolution
- metabolic syndrome
- squamous cell carcinoma
- young adults
- radiation therapy
- stress induced
- stem cells
- neoadjuvant chemotherapy
- cell therapy
- estrogen receptor
- skeletal muscle
- high intensity
- insulin resistance
- bone marrow
- reactive oxygen species
- pregnancy outcomes
- decision making